Monashee sold 175,000 Structure Therapeutics shares in a trade estimated at approximately $11.98 million based on the quarter's mean unadjusted close. The transaction is a notable ownership-flow event, but the article provides no operating update or fundamental catalyst. Market impact is likely limited unless followed by additional selling or related disclosures.
Monashee sold 175,000 Structure Therapeutics shares in a trade estimated at approximately $11.98 million based on the quarter's mean unadjusted close. The transaction is a notable ownership-flow event, but the article provides no operating update or fundamental catalyst. Market impact is likely limited unless followed by additional selling or related disclosures.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
-0.10
Ticker Sentiment
